DDFPe Extends Window for tPA Therapy in a Rabbit Stroke Model
- NuvOx Pharma
- Oct 31, 2015
- 1 min read
This model tested DDFPe in a reperfusion model where tPA was given at 9 hours. The results show that DDFPe is beneficial in reperfusion at 9 hours. With delayed reperfusion, DDFPe + tPA was more effective than tPA alone in preserving functioning brain after stroke. DDFPe significantly extends the time window for tPA therapy.
Comentarios